SG10201608485XA - (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel - Google Patents
(r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratelInfo
- Publication number
- SG10201608485XA SG10201608485XA SG10201608485XA SG10201608485XA SG10201608485XA SG 10201608485X A SG10201608485X A SG 10201608485XA SG 10201608485X A SG10201608485X A SG 10201608485XA SG 10201608485X A SG10201608485X A SG 10201608485XA SG 10201608485X A SG10201608485X A SG 10201608485XA
- Authority
- SG
- Singapore
- Prior art keywords
- nifuratel
- infections
- synthesis
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C241/00—Preparation of compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C241/02—Preparation of hydrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20120167640 EP2662371A1 (en) | 2012-05-11 | 2012-05-11 | (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201608485XA true SG10201608485XA (en) | 2016-12-29 |
Family
ID=47846051
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201406447SA SG11201406447SA (en) | 2012-05-11 | 2013-03-13 | (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel |
SG10201608485XA SG10201608485XA (en) | 2012-05-11 | 2013-03-13 | (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201406447SA SG11201406447SA (en) | 2012-05-11 | 2013-03-13 | (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel |
Country Status (27)
Country | Link |
---|---|
US (2) | US9284306B2 (en) |
EP (2) | EP2662371A1 (en) |
JP (1) | JP2015515998A (en) |
KR (1) | KR20150008871A (en) |
CN (1) | CN104379580A (en) |
AU (1) | AU2013258385A1 (en) |
BR (1) | BR112014027953A2 (en) |
CA (1) | CA2869827A1 (en) |
CL (1) | CL2014002951A1 (en) |
CO (1) | CO7131368A2 (en) |
CR (1) | CR20140505A (en) |
DO (1) | DOP2014000252A (en) |
EA (1) | EA201492081A1 (en) |
EC (1) | ECSP14026432A (en) |
GE (2) | GEP201706626B (en) |
HK (1) | HK1202539A1 (en) |
IL (1) | IL235429A0 (en) |
IN (1) | IN2014DN09256A (en) |
MA (1) | MA20150279A1 (en) |
MX (1) | MX2014013759A (en) |
NZ (1) | NZ700752A (en) |
PE (1) | PE20150167A1 (en) |
PH (2) | PH12014502500A1 (en) |
SG (2) | SG11201406447SA (en) |
TN (1) | TN2014000430A1 (en) |
WO (1) | WO2013167295A1 (en) |
ZA (1) | ZA201407596B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108254453A (en) * | 2016-12-28 | 2018-07-06 | 苏州电器科学研究院股份有限公司 | A kind of effective detection method for measuring phthalic acid ester content in plastic products |
IL302943A (en) | 2017-09-20 | 2023-07-01 | Ph Pharma Co Ltd | Thailanstatin analogs |
CN108760950B (en) * | 2018-04-25 | 2022-07-15 | 国检测试控股集团京诚检测有限公司 | Method for determining nitrofuran metabolite |
CN111892557B (en) * | 2019-05-05 | 2022-11-08 | 河北圣泰材料股份有限公司 | Synthetic method of piperazine film-forming ionic liquid |
CN110672765B (en) * | 2019-10-11 | 2022-03-18 | 温州海鹤药业有限公司 | Method for quantitatively detecting cis-isomer impurities in nifuratel |
CN112457304B (en) * | 2020-12-07 | 2022-03-11 | 中国药科大学 | Preparation method of nifuratel |
CN113828243B (en) * | 2021-09-14 | 2022-06-28 | 南京南大药业有限责任公司 | Method and equipment for manufacturing nifuratel nystatin suppository |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE635608A (en) | 1962-08-01 | |||
CN100506820C (en) | 2006-03-16 | 2009-07-01 | 韩志强 | (S)-nifuratel, preparation method and application thereof |
CN100516063C (en) * | 2006-03-16 | 2009-07-22 | 韩志强 | Production method of nifuratel |
CN101434584A (en) * | 2007-11-15 | 2009-05-20 | 中山大学 | Chiral oxazolidinone compound with antibacterial activity |
EP2243482A1 (en) * | 2009-04-20 | 2010-10-27 | Polichem SA | Use of nifuratel to treat infections caused by atopobium species |
-
2012
- 2012-05-11 EP EP20120167640 patent/EP2662371A1/en not_active Withdrawn
-
2013
- 2013-03-13 WO PCT/EP2013/055078 patent/WO2013167295A1/en active Application Filing
- 2013-03-13 NZ NZ700752A patent/NZ700752A/en not_active IP Right Cessation
- 2013-03-13 IN IN9256DEN2014 patent/IN2014DN09256A/en unknown
- 2013-03-13 US US14/400,071 patent/US9284306B2/en not_active Expired - Fee Related
- 2013-03-13 SG SG11201406447SA patent/SG11201406447SA/en unknown
- 2013-03-13 SG SG10201608485XA patent/SG10201608485XA/en unknown
- 2013-03-13 AU AU2013258385A patent/AU2013258385A1/en not_active Abandoned
- 2013-03-13 KR KR20147031517A patent/KR20150008871A/en not_active Application Discontinuation
- 2013-03-13 GE GEAP201313967A patent/GEP201706626B/en unknown
- 2013-03-13 CA CA 2869827 patent/CA2869827A1/en not_active Abandoned
- 2013-03-13 PE PE2014001944A patent/PE20150167A1/en not_active Application Discontinuation
- 2013-03-13 EP EP13708840.7A patent/EP2847189A1/en not_active Withdrawn
- 2013-03-13 MX MX2014013759A patent/MX2014013759A/en unknown
- 2013-03-13 GE GEAP201313660A patent/GEP201606595B/en unknown
- 2013-03-13 BR BR112014027953A patent/BR112014027953A2/en not_active IP Right Cessation
- 2013-03-13 CN CN201380022803.0A patent/CN104379580A/en active Pending
- 2013-03-13 EA EA201492081A patent/EA201492081A1/en unknown
- 2013-03-13 MA MA37496A patent/MA20150279A1/en unknown
- 2013-03-13 JP JP2015510685A patent/JP2015515998A/en active Pending
-
2014
- 2014-10-16 TN TN2014000430A patent/TN2014000430A1/en unknown
- 2014-10-20 ZA ZA2014/07596A patent/ZA201407596B/en unknown
- 2014-10-30 IL IL235429A patent/IL235429A0/en unknown
- 2014-10-30 CL CL2014002951A patent/CL2014002951A1/en unknown
- 2014-11-03 CR CR20140505A patent/CR20140505A/en unknown
- 2014-11-07 DO DO2014000252A patent/DOP2014000252A/en unknown
- 2014-11-10 PH PH12014502500A patent/PH12014502500A1/en unknown
- 2014-11-11 EC ECIEPI201426432A patent/ECSP14026432A/en unknown
- 2014-11-11 CO CO14248543A patent/CO7131368A2/en unknown
-
2015
- 2015-01-28 US US14/607,464 patent/US9067927B2/en not_active Expired - Fee Related
- 2015-03-26 HK HK15103057.7A patent/HK1202539A1/en unknown
- 2015-09-24 PH PH12015502241A patent/PH12015502241A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202003200B (en) | Compositions, methods, and systems for the synthesis and use of imaging agents | |
HK1218110A1 (en) | Sulfamoyl arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
ZA201500921B (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diaseases | |
HK1211589A1 (en) | Compounds for the treatment of paramoxyvirus viral infections | |
ZA201405820B (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
HK1210030A1 (en) | Sulfamoyl aryamides and the use thereof as medicaments for the treatment of hepatitis b | |
EP2675469A4 (en) | Compositions, devices and methods of use thereof for the treatment of cancers | |
SG2014008304A (en) | C10rf32 antibodies, and uses thereof for treatment of cancer | |
HK1220324A1 (en) | Methods, compounds, and compositions for the treatment of angiotensin-related diseases | |
EP3068442A4 (en) | Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent | |
IL235429A0 (en) | (r)-nifuratel, its use for the treatment of infections and synthesis of (r) and (s)-nifuratel | |
EP2867239A4 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes | |
HRP20181879T1 (en) | Compounds for the treatment of obesity and methods of use thereof | |
EP3015077A4 (en) | Treatment instrument for endoscope, and endoscope system | |
AP2015008338A0 (en) | Compounds for the treatment and prevention of retroviral infections | |
HK1206348A1 (en) | Cyclohexane-1,2-indene-1,2-imidazol compounds and their use as bace inhibitors -12--12- bace | |
HK1246694A1 (en) | Use of thymosin alpha for the treatment of sepsis | |
EP3044321A4 (en) | New marker for the classification, diagnosis and treatment of scoliosis | |
EP2800568A4 (en) | Compositions, methods of use, and methods of treatment | |
ZA201408065B (en) | Compositions and methods for the treatment of diabetes | |
PL2855475T3 (en) | Alpha-carbolines for the treatment of cancer | |
HK1210421A1 (en) | Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3- | |
IL232339A0 (en) | C10rf32 antibodies , and uses thereof for treatment of cancer | |
GB201208770D0 (en) | Compounds for use in the treatment of adenovirus infections | |
AU2013900781A0 (en) | Nacre-like composites, methods of synthesis and methods of use |